Franklin Templeton Etf Tr genomic adv etf shares owned by UBS Group
Quarter-by-quarter ownership of Franklin Templeton Etf Tr genomic adv etf (HELX) shares owned by UBS Group
from 13F filings
Historical chart of UBS Group investment in Franklin Templeton Etf Tr genomic adv etf
Tip: Access up to 7 years of quarterly data
All positions including Franklin Templeton Etf Tr genomic adv etf held by UBS Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Franklin Templeton Etf Tr genomic adv etf by UBS Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $1.6k | 44 | 36.30 |
| 2025-06-30 | $24k | 863 | 27.71 |
| 2025-03-31 | $72k | 2.7k | 27.00 |
| 2024-12-31 | $61k | 2.1k | 28.85 |
| 2024-09-30 | $15k | 449 | 32.41 |
| 2024-06-30 | $1.3k | 42 | 31.69 |
| 2023-12-31 | $50k | 1.6k | 30.47 |
| 2023-09-30 | $1.1k | 40 | 28.33 |
| 2022-12-31 | $18k | 603 | 30.13 |
| 2022-09-30 | $43k | 1.5k | 29.45 |
| 2022-06-30 | $40k | 1.2k | 32.10 |
| 2022-03-31 | $74k | 2.0k | 37.09 |
| 2021-12-31 | $62k | 1.3k | 48.14 |
| 2020-03-31 | $0 | 3 | 0.00 |
Top funds holding Franklin Templeton Etf Tr genomic adv etf
View all funds holding Franklin Templeton Etf Tr genomic adv etf